A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/05 (2006.01) A61K 45/00 (2006.01) A61K 45/06 (2006.01) A61P 9/10 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2407633
The present invention has for its object to provide a method and a composition for achieving a more efficient recovery of the antioxidant activity of plasma LDL, or even augmentation thereof, which has been depressed by the use of an antihyperlipidemic or cholesterol-lowering drug to thereby insure a potentiated antiarteriosclerotic efficacy. A method for inhibiting arteriosclerosis, which comprises using a combination of a cholesterol-lowering agent and a reduced coenzyme Q10 represented by the following formula (1), and a composition for inhibiting arteriosclerosis containing both a cholesterol-lowering agent and said reduced coenzyme Q10. (see formula 1)
L'invention concerne un procédé et des compositions permettant d'inhiber l'artériosclérose avec un effet potentialisé, grâce à un rétablissement plus efficace de la diminution de la fonction antioxydative de lipoprotéine de basse densité du plasma engendrée par l'hyperlipidémie ou l'utilisation d'un hypocholestérolémiant, ou grâce à une amélioration de la fonction. L'invention concerne précisément un procédé qui permet d'inhiber l'artériosclérose en utilisant une combinaison d'hypocholestérolémiant et de coenzyme Q¿10? réduite, selon la formule (1) ci-après. L'invention concerne également des compositions permettant d'inhiber l'artériosclérose qui renferment un hypocholestérolémiant et la coenzyme réduite en question.
Fujii Kenji
Hidaka Takayoshi
Hosoe Kazunori
Kawabe Taizo
Kaneka Corporation
Riches Mckenzie & Herbert Llp
LandOfFree
Method and compositions for inhibiting arteriosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions for inhibiting arteriosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for inhibiting arteriosclerosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1759550